Rare diseases
Investigational molecules
Locations
35 Rue De Verdun, 92284 Suresnes, France
Servier Affaires Medicales is involved in clinical research for isocitrate dehydrogenase 1 mutation-positive acute myeloid leukemia, with a focus on adult patients who are not candidates for intensive induction chemotherapy.
The sponsor’s research activity in this area centers on targeted oncology care for genetically defined blood cancers.
Servier Affaires Medicales runs clinical trials in conditions such as Cholangiocarcinoma, Acute myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
AustriaStudy of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
AustriaStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
